🇺🇸 FDA
Pipeline program

Atomoxetine 80mg combined with oxybutynin 5mg

CMUH112-REC3-201

Approved small_molecule completed

Quick answer

Atomoxetine 80mg combined with oxybutynin 5mg for Obstructive Sleep Apnea of Adult is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Obstructive Sleep Apnea of Adult
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials